<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0611234434
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2023
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Acyclovir - Vaxcel
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        ACYCLOVIR
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        250
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Powder for infusion
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Vial
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        48
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        193.50
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Kotra Pharma M Sdn Bhd" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Kotra Pharma M Sdn Bhd
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 657]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Al-Safa Warehouse For Pharmaceuticals Ltd
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Kotra pharma M Sdn Bhd
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J05AB01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Acyclovir-Vaxcel contains a medicine called acyclovir. This belongs to a group of medicines<br />called antivirals. It works by killing or stopping the growth of viruses.<br />Acyclovir-Vaxcel can be used to:<br />- treat chickenpox<br />- treat severe cases of genital herpes<br />- treat and stop cold sores and genital herpes in people whose immune systems work less well,<br />which means their bodies are less able to fight infections<br />- treat serious virus infections in children up to 3 months of age. This can rarely be caused by<br />the virus responsible for cold sore infection and genital herpes<br />- treat inflammation of the brain. This can rarely be caused by the virus responsible for cold sore<br />infection and genital herpes<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not have Acyclovir-Vaxcel:<br />- If you are allergic acyclovir or valacyclovir<br />Do not take Acyclovir-Vaxcel if the above applies to you. If you are not sure, talk to your doctor or<br />pharmacist before having Acyclovir-Vaxcel.<br />Talk to your doctor or pharmacist before having Acyclovir-Vaxcel if:<br />- you have kidney problems<br />- you are over 65 years of age<br />If you are not sure if the above applies to you, talk to your doctor or pharmacist before taking<br />Acyclovir-Vaxcel.<br />It is important that you drink plenty of water while taking Acyclovir-Vaxcel.<br />Other medicines and Acyclovir-Vaxcel:<br />Tell your doctor or pharmacist if you are taking, have recently taken or might take any other<br />medicines. This includes medicines obtained without a prescription, including herbal medicines. In<br />particular tell your doctor or pharmacist if you are taking any of the following medicines:<br />&bull; probenecid, used to treat gout<br />&bull; cimetidine, used to treat stomach ulcers.<br />&bull; tacrolimus, ciclosporin or mycophenolate mofetil, used to stop your body rejecting transplanted<br />organs.</p><p><strong><u>Pregnancy, breast-feeding and fertility</u></strong><br />If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.<br />This medicine contains sodium. You should tell your doctor or pharmacist if you are on a controlled sodium diet.<br />If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before taking this medicine.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Acyclovir-Vaxcel will be given to you by a person who is trained to do so. Before the medicine is given to you it will be diluted. Acyclovir-Vaxcel will be given to you as a continuous infusion into your vein. This is where the drug is slowly given to you over a period of time. The dose you will be given, the frequency and the duration of the dose will depend on:<br />&bull; the type of infection you have<br />&bull; your weight<br />&bull; your age</p><p><br />Your doctor may adjust the dose of Acyclovir-Vaxcel if:<br />&bull; you have kidney problems. If you have kidney problems, it is important that you receive plenty of fluids while you are being treated with Acyclovir-Vaxcel Talk to your doctor before having Acyclovir-Vaxcel if any of the above apply.</p><p>If you are given too much Acyclovir-Vaxcel:<br />If you think you have been given too much Acyclovir-Vaxcel, talk to your doctor or nurse straight<br />away. If you have been given too much Acyclovir-Vaxcel you may:<br />&bull; feel confused or agitated<br />&bull; have hallucinations (seeing or hearing things that aren&rsquo;t there)<br />&bull; have fits.<br />&bull; become unconscious (coma)<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Acyclovir-Vaxcel can cause side effects, although not everybody gets them. The following side effects may happen with this medicine:</p><p>Allergic reactions (may affect up to 1 in 10,000 people)<br />If you have an allergic reaction, stop taking Acyclovir-Vaxcel and see a doctor straight away. The signs may include:<br />- rash, itching or hives on your skin<br />- swelling of your face, lips, tongue or other parts of your body<br />- shortness of breath, wheezing or trouble breathing<br />- unexplained fever (high temperature) and feeling faint, especially when standing up.</p><p>Other side effects include:<br />Common (may affect up to 1 in 10 people)<br />- feeling or being sick<br />- Itchy, hive-like rash<br />- skin reaction after exposure to light (photosensitivity)<br />- itching<br />- swelling, redness and tenderness at the site of injection<br />- increase in the liver enzymesز</p><p>Uncommon (may affect up to 1 in 100 people)<br />- reduced numbers of red blood cells (anaemia)<br />- reduced numbers of white blood cells (leukopenia)<br />- reduced numbers of blood platelets (cells that help the blood to clot) (thrombocytopenia)<br />Very rare (may affect up to 1 in 10,000 people)<br />- headache or feeling dizzy<br />- diarrhea or stomach pain<br />- feeling tired<br />- fever<br />- effects on some blood urine tests<br />- feeling weak<br />- feeling agitated or confused<br />- shaking or tremors<br />- hallucinations (seeing or hearing things that aren&#39;t there)<br />- fits<br />- feeling unusually sleepy or drowsy<br />- unsteadiness when walking and lack of coordination<br />- difficulty speaking<br />- inability to think or judge clearly<br />- unconsciousness (coma)<br />- paralysis of part or all of your body<br />- disturbances of behaviour, speech and eye movements<br />- stiff neck and sensitivity to light<br />- inflammation of the liver (hepatitis)<br />- yellowing of your skin and whites of your eyes (jaundice)<br />- kidney problems where you pass little or no urine<br />- pain in your lower back, the kidney area of your back, or just above your hip (renal pain)</p><p>If you get side effects:<br />➔ Tell your doctor or pharmacist if any of the side effects listed become severe or troublesome, or if you notice any side effects not listed in this leaflet.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>- Keep this medicine out of the sight and reach of children.<br />- Do not use Acyclovir-Vaxcel after the expiry date on the vial. The expiry date refers to the last day of that month.<br />- Store below 30oC.<br />- Prepare immediately before use. After reconstitution, store below 25&deg;C for 48 hours. Do not refrigerate. Protect from light.<br />- If your doctor told you to stop taking this medicine return any unused Acyclovir-Vaxcel to your pharmacist to be destroyed.<br />- Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>- The active ingredient is Acyclovir sodium<br />- Each vial contains Acyclovir sodium equivalent to Acyclovir 250mg.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                - The medicine appears as white to off white crystalline powder.
- This medicine is packed in a clear glass vial.
- There are 10 vials of Acyclovir-Vaxcel in an outer carton with package insert
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Kotra Pharma (M) Sdn. Bhd.<br />No. 1, 2 &amp; 3, Jalan TTC 12,<br />Cheng Industrial Estate, 75250<br />Melaka, Malaysia<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised on 15 May 2023

* To report any side effect (s):
-Kingdom of Saudi Arabia
- National Pharmacovigilance Center (NPC)
- SFDA call center: 19999
-E-Mail: npc.drug@sfda.gov.sa
- Website: https://ade.sfda.gov.sa/

This is a medicament
• Medicament is a product which affects your health and its consumption contrary to
instruction is dangerous for you.
• Follow strictly the doctor’s prescription, the method of use and the instructions of the
pharmacist who sold the medicament.
• The doctor and the pharmacist are the experts in medicines, their benefits and risks.
• Do not by yourself interrupt the period of treatment prescribed for you.
• Do not repeat the same prescription without consulting your doctor.
• Keep all medicaments out of reach of children.

            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>يحتوي أسيكلوفير-فاكسيل الوريدي المسمى &quot; أسيكلوفير-فاكسيل &quot; في هذه النشرة (على دواء اسمه أسيكلوفير. وهو ينتمي إلى فئة من الأدوية تسمى مضادات الفيروسات. ويظهر تأثيره العلاجي بالقضاء على نمو الفيروسات أو إيقافه.</p><p><br />يمكن استخدام أسيكلوفير-فاكسيل للأغراض التالية:<br />&bull;علاج الحماق<br />&bull;علاج الحالات الحادة لهربس الأعضاء التناسلية<br />&bull;علاج قرحات الزكام وهربس الأعضاء التناسلية وإيقافها لدى الأشخاص الذين يعانون من ضعف الجهاز المناعي، مما يعني<br />أن أجسامهم أقل قدرة على مكافحة العدوى.<br />&bull;علاج العدوى الفيروسية الخطيرة في الأطفال حتى 3أشهر من العمر. نادرا ما قد يحدث هذا بفعل الفيروس المسؤول عن<br />عدوى قرحات الزكام وهربس الأعضاء التناسلية.<br />&bull;علاج التهاب الدماغ. نادرا ما قد يحدث هذا بفعل الفيروس المسؤول عن عدوى قرحات الزكام وهربس الأعضاء التناسلية<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>تجنّب استخدام أسيكلوفير-فاكسيل:<br />&nbsp;في حالة وجود حساسية لمادة الأسيكلوفير أو الفالسيكلوفير أو لأي مكون من المكونات الأخرى الخاصة بهذا الدواء) المذكورة في القسم 6<br />لا تستخدم أسيكلوفير-فاكسيل إذا كانت أي من الحالات السابقة تنطبق عليك. وفي حالة عدم التأكد من ذلك، ينبغي استشارة الطبيب أو الصيدلي قبل استخدام أسيكلوفير-فاكسيل.</p><p><strong>تحذيرات واحتياطات</strong><br />يجب استشارة الطبيب أو الصيدلي قبل استخدام أسيكلوفير-فاكسيل في الحالات الآتية:<br />&bull;وجود مشكلات في الكلى<br />&bull;إذا كان عمرك يزيد عن 65عاما.</p><p><br />في حالة عدم التأكد مما إذا كان ما ذ ُكر أعلاه ينطبق عليك، ينبغي استشارة الطبيب أو الصيدلي قبل تناول أسيكلوفير-فاكسيل.<br />من المهم أن تشرب قدرا وفيرا من الماء أثناء تناول أسيكلوفير-فاكسيل.</p><p><br /><strong>الأدوية الأخرى وأسيكلوفير-فاكسيل</strong><br />أخبر الطبيب أو الصيدلي إذا كنت تتناول أدوية أخرى أو تناولت أي أدوية أخرى مؤخرا أو قد تتناول أدوية أخرى. ويشمل ذلك الأدوية التي يتم الحصول عليها دون وصفة طبية، بما<br />في ذلك الأدوية العشبية.<br />بصفة خاصة، ينبغي عليك إخبار الطبيب أو الصيدلي إذا كنت تتناول أي دواء من الأدوية التالية:<br />&bull;بروبينسيد، المستخدم لعلاج النقرس<br />&bull;السيميتيدين، المستخدم لعلاج قرح المعدة<br />&bull;التاكروليموس أو سيكلوسبورين أو ميكوفينولات موفيتيل، المستخدم لمنع رفض جسمك للأعضاء المزروعة الحمل والرضاعة الطبيعية والخصوبة في حالة الحمل أو الرضاعة الطبيعية أو إذا كنت تظنين أنك حامل أو تخططين للحمل، فيجب استشارة الطبيب أو الصيدلي قبل ااستخدام هذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>كيفية إعطاء الدواء الخاص بك.<br />ليس من المتوقع أبدا أن تعطي لنفسك هذا الدواء. ينبغي دائما أن يكون من يعطيك هذا الدواء شخصا متدربا على القيام بهذا.<br />قبل إعطاء الدواء لك سيتم تخفيفه.<br />سيتم إعطاء أسيكلوفير-فاكسيل لك كتسريب مستمر في وريدك. هذا هو المكان الذي يتم إعطاء الدواء لك فيه ببطء خلال فترة زمنية.<br />ستتوقف الجرعة التي سيتم إعطاؤها لك ومعدل تكرارها ومدتها على:<br />&bull;نوع العدوى التي تعاني منها<br />&bull;وزنك<br />&bull;عمرك</p><p><br />قد يقوم الطبيب بتعديل جرعة أسيكلوفير-فاكسيل في الحالات التالية:<br />&bull;وجود مشكلات في الكلى. إذا كنت تعاني من مشكلات بالكلى، فإنه من المهم أن تحصل على قدر وفير من السوائل أثناء علاجك<br />بدواء فاكسيل أسيكلوفير.<br />ينبغي استشارة الطبيب قبل تناول أسيكلوفير-فاكسيل أو في حالة وجود أ ّي مما سبق.</p><p>إذا أُعطيت جرعة زائدة من أسيكلوفير-فاكسيل:<br />إذا كنت تعتقد أنه قد تم إعطاؤك جرعة زائدة من أسيكلوفير-فاكسيل، ينبغي استشارة الطبيب أو الممرضة على الفور.<br />إذا أُعطيت جرعة زائدة من أسيكلوفير-فاكسيل فقد:<br />&bull;تشعر بالارتباك أو الاضطراب<br />&bull;تعاني من الهلاوس (رؤية أو سماع أشياء غير موجودة).<br />&bull;تعاني من النوبات<br />&bull;تفقد الوعي (الغيبوبة).<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جميع الأدوية، يمكن أن يتسبب هذا الدواء في حدوث أعراض جانبية، لكن ليس بالضرورة أن يُصاب بها جميع الأشخاص. قد تحدث الآثار الجانبية التالية عند تناول هذا الدواء:<br />تفاعلات الحساسية (قد تؤثر على نسبة تصل إلى شخص واحد من كل 10,000شخص)<br />في حالة الإصابة بتفاعل الحساسية، ينبغي التوقف عن تناول أسيكلوفير-فاكسيل واستشارة طبيبك على الفور. قد تشمل العلامات:<br />&bull;الطفح أو الحكة أو الشرى على جلدك<br />&bull;تورم وجهك أو شفتيك أو لسانك أو أجزاء أخرى من جسمك<br />&bull;ضيق التنفس أو أزيز في الصدر أو صعوبة في التنفس<br />&bull;حمى مجهولة السبب (ارتفاع درجة الحرارة) والشعور بالإغماء، ولا سيما عند الوقوف<br />&nbsp;</p><p><strong>تشمل الآثار الجانبية الأخرى:</strong><br /><strong>شائعة (قد تؤثر على نسبة تصل إلى شخص واحد من كل 10أشخاص)</strong><br />&bull;الشعور بالتوعك أو الإعياء<br />&bull;الحكة، طفح يشبه الانتبار<br />&bull;تفاعل البشرة بعد التعرض للضوء (الحساسية للضوء)<br />&bull;الحكة<br />&bull;التورم، والاحمرار، والألم في موضع الحقن.<br />&bull;زيادة أنزيمات الكبد.</p><p>&nbsp;</p><p><strong>غير شائعة (قد تؤثر على نسبة تصل إلى شخص واحد من كل 100شخص)</strong><br />&bull;انخفاض عدد خلايا الدم الحمراء (فقر الدم)<br />&bull;انخفاض عدد خلايا الدم البيضاء (قلة الكريات البيض)<br />&bull;انخفاض عدد الصفائح الدموية (خلايا تساعد الدم في التجلط) (نقص الصفائح الدموية)</p><p><br /><strong>الآثار النادرة جدا (قد تؤثر على نسبة تصل إلى شخص واحد من كل 10,000شخص)</strong><br />&bull;الصداع أو الشعور بالدوار<br />&bull;الإسهال أو آلام المعدة<br />&bull;الشعور بالإجهاد<br />&bull;الحمى<br />&bull;التأثيرات على بعض اختبارات الدم والبول<br />&bull;الشعور بالضعف<br />&bull;الشعور بالاضطراب أو الارتباك<br />&bull;الارتجاف أو الرعاش<br />&bull;الهلاوس (رؤية أو سماع أشياء غير موجودة(<br />&bull;النوبات<br />&bull;الشعور بالخمول أو النعاس غير المعتاد<br />&bull;عدم الثبات أثناء المشي وفقد الاتزان<br />&bull;صعوبة الكلام<br />&bull;العجز عن التفكير أو الحكم بوضوح<br />&bull;فقدان الوعي (الغيبوبة)<br />&bull;شلل جزء من الجسم أو الجسم كله<br />&bull;اضطرابات السلوك والكلام وحركات العينين<br />&bull;تيبس الرقبة والحساسية للضوء<br />&bull;التهاب الكبد (الوبائي)<br />&bull;اصفرار الجلد أو بياض العينين (اليرقان)<br />&bull;مشكلات في الكلى حيث تُخرج قليلا من البول أو لا تُخرجه على الإطلاق<br />&bull;ألم أسفل الظهر، منطقة الكلى في الظهر أو أعلى الورك مباشرة (ألم كلوي)<br />في حالة الإصابة بالآثار الجانبية<br />أبلغ الطبيب أو الصيدلي في حالة تفاقم أي من الأعراض الجانبية الموضحة هنا أو إذا أصبحت مزعجة، أو إذا لاحظت أي أعراض جانبية غير مبيَّنة في هذه النشرة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><br />- يحفظ بعيدا عن متناول أيدي الاطفال.<br />- يحفظ في درجة حرارة لا تزيد عن 30درجة مئوية.<br />- بعد الإحلال تحفظ في درجة حرارة أقل من 25درجة مئوية لمدة 48ساعة. لا يبرد. يحفظ بعيدا عن الضوء.<br />- لا تستخدم أسيكلوفير 250ملغم للتسريب عبر الوريد بعد تاريخ انتهاء الصلاحية المدون على الملصق. يشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من نفس الشهر.<br />- يجب تحضيره مباشرة قبل الاستخدام. بمجرد تحويل المسحوق إلى محلول ، قم بتخزينه في درجة حرارة أقل من 25درجة مئوية<br />لمدة 48ساعة.</p><p>-&nbsp;</p><table><tbody><tr><td>إذا أخبرك طبيبك بالتوقف عن تناول هذا الدواء، فقم بإرجاع أي كمية غير مستخدمة من أسيكلوفير-فاكسيل 250ملغم للصيدلي</td><td>الخاص بك لاتلاف</td></tr></tbody></table><p>-</p><table><tbody><tr><td>لا يجوز رمي الأدوية في مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد</td></tr><tr><td>تستخدمها. ومن شأن هذه التدابير أن تساعد على حماية البيئة</td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>-المادة الفعالة هي الأسيكلوفير الصوديوم<br />- تحتوي كل عبوة على أسيكلوفير صوديوم ما يكافئ 250ملغم أسيكلوفير<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>- يظهر الدواء على شكل مسحوق بلوري أبيض إلى أبيض مصفر.<br />- هذا الدواء معبأ في عبوة زجاجية شفافة.<br />- يوجد 10قوارير/عبوات من أسيكلوفير-فاكسيل في علبة كرتونية خارجية مع نشرة داخلية<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>Kotra Pharma (M) Sdn. Bhd.<br />No. 1, 2 &amp; 3, Jalan TTC 12,<br />Cheng Industrial Estate,<br />75250 Melaka, Malaysia<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            2023/5/15

-للإبلاغ حول الأعراض الجنبية التي قد تحدث يرجى التواصل عبر العناوين التالية:
المملكة العربية السعودية:
المركز الوطني للتيقظ الدوائي :
مركز االتصال الموحد: 19999
البريد الإكتروني: npc.drug@sfda.gov.sa 
الموقع الإلكتروني: https://ade.sfda.gov.sa

إن هذا الدواء
- الدواء مستحضر يؤثر على صحتك واستهالكه خلافا للتعليمات يعرضك للخطر.
- اتبع بدقة وصفة الطبيب، وطريقة الاستعمال المنصوص عليها، وتعليمات الصيدلي الذي صرفها لك.
- الطبيب والصيدلي هما الخبيران في الدواء، وفي نفعه وضرره.
- لا تقطع مدة العلاج المحددة لك من تلقاء نفسك.
- لا تكرر صرف الدواء بدون استشارة الطبيب المختص .
- لا تترك الأدوية في متناول الأطفال.
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Acyclovir-Vaxcel
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each vial contains Acyclovir (as Acyclovir Sodium) 250mg
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Sterile powder for intravenous infusion.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Acyclovir-Vaxcel is indicated:<br />1. For the treatment of Herpes simplex infections in immunocompromised patients<br />and severe initial genital herpes in the non-immunocompromised.<br />2. For the prophylaxis of Herpes simplex infections in immune-compromised<br />patients.<br />3. For the treatment of Varicella zoster infections.<br />4. For the treatment of herpes encephalitis.<br />5. For the treatment of Herpes simplex infections in the neonate and infant up to 3<br />months of age.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>A course of treatment with Acyclovir intravenous infusion usually lasts 5 days, but&nbsp;this may be adjusted according to the patient&#39;s condition and response to therapy.<br />Treatment for herpes encephalitis and neonatal Herpes simplex infections usually lasts 10 days. Treatment for neonatal herpes infections usually lasts 14 days for mucocutaneous (skin-eye-mouth) infections and 21 days for disseminated or central nervous system disease.<br />The duration of prophylactic administration of Acyclovir intravenous infusion is determined by the duration of the period at risk.</p><p><strong>Dosage in adults:</strong><br />Patients with Herpes simplex (except herpes encephalitis) or Varicella zoster infections should be given Acyclovir intravenous infusion in doses of 5mg/kg body weight every 8 hours provided renal function is not impaired.</p><p>Immunocompromised patients with Varicella zoster infections or patients with herpes encephalitis should be given Acyclovir intravenous infusion in doses of 10 mg/kg body weight every 8 hours provided renal function is not impaired.</p><p>In obese patients dosed with intravenous acyclovir based on their actual body weight,<br />higher plasma concentrations may be obtained. Consideration should therefore be given to dosage reduction in obese patients and especially in those with renal impairment or the elderly.</p><p><strong>Dosage in infants and children:</strong><br />The dose of Acyclovir intravenous infusion for infants and children aged between 3 months and 12 years is calculated on the basis of body surface area.</p><p>Infants and children 3 months of age or older with Herpes simplex (except herpes encephalitis) or Varicella zoster infections should be given Acyclovir intravenous infusion in doses of 250 mg per square metre of body surface area every 8 hours if renal function is not impaired.</p><p><br />In immunocompromised children with Varicella zoster infections or children with herpes encephalitis, Acyclovir intravenous infusion should be given in doses of 500 mg per square meter body surface area every 8 hours if renal function is not impaired.</p><p>The dosage of Acyclovir intravenous infusion in neonates and infants up to 3 months of age is calculated on the basis of body weight.</p><p>The recommended regimen for infants treated for known or suspected neonatal herpes is arovir 20 mg/kg body weight IV every 8 hours for 21 days for disseminated and CNS disease, or for 14 days for disease limited to the skin and mucous membranes.</p><p>Infants and children with impaired renal function require an appropriately modified dose, according to the degree of impairment.</p><p><strong>Dosage in the elderly:</strong><br />The possibility of renal impairment in the elderly must be considered and the dosage<br />should be adjusted accordingl. Adequate hydration should be maintained.</p><p><strong>Dosage in impairment:</strong><br />Caution is advised when administering Acyclovir intravenous infusion to patients with impaired renal function. Adequate hydration should be maintained.<br />Dosage adjustment for patients with renal impairment is based on creatinine clearance, in units of ml/min for adults and adolescents and in units of<br />ml/min/1.73m2 for infants and children less than 13 years of age.<br />The following adjustments in dosage are suggested:</p><p>&nbsp;</p><p><u><strong>Dosage adjustments in adults and adolescents</strong></u><br />&nbsp;</p><table><tbody><tr><td>Creatinine Clearance</td><td>Dosage</td></tr><tr><td>25 to 50 ml/min</td><td>The dose recommended above (5 or 10 mg/kg<br />body weight) should be given every 12 hours</td></tr><tr><td>10 to 25 ml/min</td><td>The dose recommended above (5 or 10 mg/kg<br />body weight) should be given every 24 hours.</td></tr><tr><td>0 (anuric) to 10<br />ml/min</td><td>In patients receiving continuous ambulatory<br />peritoneal dialysis (CAPD) the dose&nbsp;<table><tbody><tr><td>recommended above (5 or 10mg/kg body<br />weight) should be halved and administered<br />every 24 hours.<br />In patients receiving haemodialysis the dose<br />recommended above (5 or 10 mg/kg body<br />weight) should be halved and administered<br />every 24 hours and after dialysis.</td></tr></tbody></table></td></tr></tbody></table><p><u><strong>Dosage adjustments in infants and children</strong></u></p><p>&nbsp;</p><table><tbody><tr><td>Creatinine Clearance</td><td>Dosage</td></tr><tr><td>25 to 50<br />ml/min/1.73m2</td><td>The dose recommended above (250 or<br />500mg/m2 body surface area or 20 mg/kg<br />body weight) should be given every 12 hours.</td></tr><tr><td>10 to 25<br />ml/min/1.73m2</td><td>The dose recommended above (250 or<br />500mg/m2 body surface area or 20 mg/kg<br />body weight) should be given every 24 hours.</td></tr><tr><td>0(anuric) to 10<br />ml/min/1.73m2</td><td>In patients receiving continuous ambulatory<br />peritoneal dialysis (CAPD) the dose<br />recommended above (250 or 500 mg/m2 body<br />surface area or 20 mg/kg body weight) should<br />be halved and administered every 24 hours.<br />In patients receiving haemodialysis the dose<br />recommended above (250 or 500 mg/m2 body<br />surface area or 20 mg/kg body weight) should<br />be halved and administered every 24 hours<br />and after diagnosis</td></tr></tbody></table><p><strong>ROUTE OF ADMINISTRATION:<br />Reconstitution:</strong><br />Acyclovir-Vaxcel should be reconstituted using the 10ml volumes of either Water for Injection, Sodium Chloride Intravenous Injection BP (0.9%w/v) to provide a solution containing 25mg/ml acyclovir.<br />For the calculated dose, determine the appropriate number and strength of vials to be used. To reconstitute each vial, add the recommended volume of infusion fluid and shake gently until the contents of the vial have dissolved completely.</p><p><strong>Administration:</strong><br />The required dose of Acyclovir-Vaxcel should be administered by slow intravenous infusion over one-hour period.<br />Alternatively, the reconstituted solution may be further diluted to give an acyclovir concentration of not greater than 5mg/ml (0.5%w/v) for administration by infusion:<br />Add the required volume of reconstituted solution to the chosen infusion solution, as recommended below, and shake well to ensure adequate mixing occurs. For children and neonates, where it is advisable to keep the volume of fluid to a minimum, it is</p><p>recommended that dilution is on the basis of 4ml reconstituted solution (100mg acyclovir) added to 20ml of infusion fluid.<br />For adults, it is recommended that infusion bags containing 100ml of infusion fluid are used, even when this would give an acyclovir concentration substantially below 0.5%w/v. Thus one 100ml infusion bag may be used for any dose between 250mg and 500mg acyclovir (10 and 20ml of reconstituted solution) but a second bag must be used for doses between 500mg and 1000mg.<br />When diluted in accordance with the recommended schedules, Acyclovir-Vaxcel is known to be compatible with the following infusion fluids and stable for up to 48 hours below 25&deg;C, beyond that unused solution should be discarded: -<br />&bull; Water for Injection<br />&bull; Sodium Chloride Intravenous Infusion BP (0.9% w/v)<br />&bull; Sodium Chloride (0.45% w/v) and Glucose (4% w/v) Intravenous Infusion<br />BP<br />&bull; Compound Sodium Lactate Intravenous Infusion BP (Hartmann&rsquo;s<br />Solution)<br />Acyclovir-Vaxcel when diluted in accordance with the above schedule will give an<br />acyclovir concentration not greater than 0.5%w/v.<br />Since no antimicrobial preservative is included, reconstitution and dilution must be<br />carried out under full aseptic conditions, immediately before use and any unused<br />solution discarded.<br />Should any visible turbidity or crystallization appear in the solution before or during<br />infusion, the preparation should be discarded.<br />Reconstituted or diluted solutions SHOULD NOT BE REFRIGERATED.<br />&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Acyclovir-Vaxcel is contraindicated in patients known to be previously hypersensitive to acyclovir or valacyclovir.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adequate hydration should be maintained in patients given iv or high oral doses of acyclovir.<br />Intravenous doses should be given by infusion over one hour to avoid precipitation of acyclovir in the kidney; rapid or bolus injection should be avoided.<br />The risk of renal impairment is increased by the use of other nephrotoxic drugs. Care is required if administering iv acyclovir with other nephrotoxic drugs.<br />&nbsp;</p><p>Use in patients with renal impairment and in elderly patients:<br />Acyclovir is eliminated by renal clearance; therefore the dose must be reduced in patients with renal impairment. Elderly patients are likely to have reduced renal function and therefore the need for dose reduction must be considered in this group of patients. Both elderly patients and patients with renal impairment are at increased risk of developing neurological side effects and should be closely monitored for evidence of these effects. In the reported cases, these reactions were generally reversible on discontinuation of treatment.<br />Prolonged or repeated courses of acyclovir in severely immunocompromised individuals may result in the selection of virus strains with reduced sensitivity, which may not respond to continued acyclovir treatment In patients receiving Vaxcel Acyclovir 250mg Injection at higher doses (e.g. for<br />herpes encephalitis), specific care regarding renal function should be taken,&nbsp; particularly when patients are dehydrated or have any renal impairment. Reconstituted Vaxcel Acyclovir 250mg Injection has a pH of approximately 11.0 and should not be administered by mouth.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Acyclovir is eliminated primarily unchanged in the urine via active renal tubular secretion. Any drugs administered concurrently that compete with this mechanism or affect renal physiology may increase acyclovir plasma concentrations. Probenecid and cimetidine increase the AUC of acyclovir by this mechanism, and reduce acyclovir renal clearance. However, no dosage adjustment is necessary because of the wide therapeutic index of acyclovir.</p><p><br />In patients receiving intravenous acyclovir, caution is required during concurrent administration with drugs which compete with acyclovir for elimination, because of the potential for increased plasma levels of one or both drugs or their metabolites.</p><p>Increases in plasma AUCs of acyclovir and of the inactive metabolite of mycophenolate mofetil, an immunosuppressant agent used in transplant patients, have been shown when the drugs are co-administered.</p><p><br />If lithium is administered concurrently with high dose acyclovir IV, the lithium serum concentration should be closely monitored because of the risk of lithium toxicity.</p><p>Care is also required (with monitoring for changes in renal function) if administering intravenous acyclovir which affect other aspects of renal physiology (e.g. cyclosporine, tacrolimus).<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Fertility:<br />There is no information on the effect of acyclovir on human female fertility.</p><p>Pregnancy:<br />Caution should be exercised by balancing the potential benefits of treatment against<br />any possible hazard.</p><p>Breast-feeding:<br />Following oral administration of 200 mg five times a day, acyclovir has been detected in human breast milk at concentrations ranging from 0.6 to 4.1 times the corresponding plasma levels. These levels would potentially expose nursing infants to acyclovir dosages of up to 0.3 mg/kg body weight/day. Caution is therefore advised if acyclovir is to be administered to a nursing woman.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Acyclovir IV for infusion is generally used in an inpatient hospital population and information on ability to drive and operate machinery is not usually relevant. There have been no studies to investigate the effect of acyclovir on driving performance or the ability to operate machinery.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The frequency categories associated with the adverse events below are estimates. For most events, suitable data for estimating incidence were not available. In addition,<br />adverse events may vary in their incidence depending on the indication.<br />The following convention has been used for the classification of undesirable effects in terms of frequency:- Very common: 1/10, common: 1/100 and &lt; 1/10, uncommon: 1/1,000 and &lt; 1/100, rare: 1/10,000 and &lt; 1/1,000, very rare: &lt; 1/10,000.<br />&nbsp;</p><table style="width:614px"><tbody><tr><td style="width:183px">System</td><td style="width:218px">Frequency</td><td style="width:125px">Adverse Events</td></tr><tr><td style="width:183px">Blood and lymphatic<br />system disorder</td><td style="width:218px">Uncommon</td><td style="width:125px">Decreases in haematological indices<br />(aneamia, thrombocytopenia, leukopenia)</td></tr><tr><td style="width:183px">Immune system disorders</td><td style="width:218px">Very rare</td><td style="width:125px">Anaphylaxis</td></tr><tr><td style="width:183px">Psychiatric and nervous<br />system disorders</td><td style="width:218px">Very rare</td><td style="width:125px">Headache, dizziness, agitation, confusion,<br />tremor, ataxia, dysarthria, hallucinations,<br />psychotic symptoms, convulsions,<br />somnolence, encephalopathy, coma</td></tr><tr><td style="width:183px">Vascular disorders</td><td style="width:218px">Common</td><td style="width:125px">Phlebitis</td></tr><tr><td style="width:183px">Respiratory, thoracic and<br />mediastinal disorders</td><td style="width:218px">Very rare</td><td style="width:125px">Dyspnoea</td></tr><tr><td style="width:183px">Gastrointestinal disorders</td><td style="width:218px">Common</td><td style="width:125px">Nausea, vomiting</td></tr><tr><td style="width:183px">Very rare</td><td style="width:218px">Diarrhoea, abdominal pain</td></tr><tr><td style="width:183px">Hepatobiliary disorders</td><td style="width:218px">Common</td><td style="width:125px">Reversible increases in liver-related<br />enzymes</td></tr><tr><td style="width:183px"><p>&nbsp;</p></td><td style="width:218px"><table><tbody><tr><td style="width:215px">Very rare</td><td style="width:12px">Reversible increases in bilirubin,</td></tr></tbody></table></td></tr></tbody></table><p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</p><table style="width:579px"><tbody><tr><td style="width:194px">&nbsp;</td></tr><tr><td style="width:194px">Skin and subcutaneous<br />tissue disorders</td><td style="width:235px">Common</td><td style="width:236px">Pruritis, urticaria, rashes (including<br />photosensitivity)</td></tr><tr><td style="width:194px">Very rare</td><td style="width:235px">Angioedema</td></tr><tr><td style="width:194px">Renal and urinary<br />disorders</td><td style="width:235px">Common</td><td style="width:236px">Increases in blood urea and creatinine.<br />Rapid increases in blood urea and<br />creatinine levels are believed to be related<br />to the peak plasma levels and the state of<br />hydration of the patient. To avoid this<br />effect the drug should not be given as an<br />intravenous bolus injection but by slow<br />infusion over a one-hour period.</td></tr><tr><td style="width:194px">Very rare</td><td style="width:235px">Renal impairment, acute renal failure.<br />Adequate hydration should be maintained.<br />Renal impairment usually responds<br />rapidly to rehydration of the patient<br />and/or dosage reduction or withdrawal of<br />the drug. Progression to acute renal<br />failure, however can occur in exceptional<br />cases. Renal pain may be associated with<br />renal failure and crystalluria</td></tr><tr><td style="width:194px">General disorders and<br />administration site<br />conditions</td><td style="width:235px">Very rare</td><td style="width:236px">Fatigue, fever, local inflammatory<br />reactions<br />Severe local inflammatory reactions<br />sometimes leading to breakdown of the<br />skin have occurred when Acyclovir<br />infusion has been inadvertantly infused<br />into extracellular tissues.</td></tr></tbody></table><p>&nbsp;</p><p>To report any side effect(s):<br />- Kingdom of Saudi Arabia<br />- National Pharmacovigilance Center (NPC)<br />o SFDA call center: 19999<br />o E-mail: npc.drug@sfda.gov.sa<br />o Website: https://ade.sfda.gov.sa/<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Symptoms and Signs:<br />Overdosage of intravenous acyclovir has resulted in elevations of serum creatinine,<br />blood urea nitrogen and subsequent renal failure. Neurological effects including<br />confusion, hallucinations, agitation, seizures and coma have been described in<br />association with overdosage.</p><p>Treatment:<br />Patients should be observed closely for signs of toxicity. Haemodialysis significantly<br />enhances the removal of acyclovir from the blood and may, therefore, be considered<br />an option in the management of overdose of this drug<br />&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Direct acting antivirals, Nucleosides and nucleotides excl. reverse transcriptase inhibitors<br />ATC code: J05AB01.<br />&nbsp;</p><p>Acyclovir is a synthetic purine nucleoside analogue with in vitro and in vivo inhibitory activity against human herpes viruses, including Herpes simplex virus types 1 and 2 and Varicella zoster virus (VZV), Epstein Barr virus (EBV) and Cytomegalovirus (CMV). In cell culture acyclovir has the greatest antiviral activity against HSV-1, followed (in decreasing order of potency) by HSV-2, VZV, EBV and CMV.</p><p><br />The inhibitory activity of acyclovir for HSV-1, HSV-2, VZV and EBV is highly selective. The enzyme thymidine kinase (TK) of normal, uninfected cells does not use acyclovir effectively as a substrate, hence toxicity to mammalian host cells is low;<br />however, TK encoded by HSV, VZV and EBV converts acyclovir to acyclovir monophosphate, a nucleoside analogue, which is further converted to the diphosphate and finally to the triphosphate by cellular enzymes.</p><p>Acyclovir triphosphate interferes with the viral DNA polymerase and inhibits viral DNA replication with resultant chain termination following its incorporation into the viral DNA.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Direct acting antivirals, Nucleosides and nucleotides excl. reverse transcriptase inhibitors<br />ATC code: J05AB01.<br />Acyclovir is a synthetic purine nucleoside analogue with in vitro and in vivo inhibitory activity against human herpes viruses, including Herpes simplex virus types 1 and 2 and Varicella zoster virus (VZV), Epstein Barr virus (EBV) and Cytomegalovirus (CMV). In cell culture acyclovir has the greatest antiviral activity against HSV-1, followed (in decreasing order of potency) by HSV-2, VZV, EBV and CMV.</p><p>The inhibitory activity of acyclovir for HSV-1, HSV-2, VZV and EBV is highly selective. The enzyme thymidine kinase (TK) of normal, uninfected cells does not use acyclovir effectively as a substrate, hence toxicity to mammalian host cells is low;<br />however, TK encoded by HSV, VZV and EBV converts acyclovir to acyclovir monophosphate, a nucleoside analogue, which is further converted to the diphosphate and finally to the triphosphate by cellular enzymes.<br />Acyclovir triphosphate interferes with the viral DNA polymerase and inhibits viral DNA replication with resultant chain termination following its incorporation into the viral DNA.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>NA</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None known.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30oC. After reconstitution, store below 25&deg;C for 48 hours.<br />Do not refrigerate. Protect from light.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Available in one vial &amp; 10 vials of sterile powder for intravenous infusion per box.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Since no antimicrobial preservative is included, reconstitution and dilution must be carried out under full aseptic conditions, immediately before use. Acyclovir-Vaxcel should be reconstituted using the 10ml volumes of either Water for Injection, or Sodium Chloride Intravenous Injection BP (0.9%w/v) to provide a solution containing 25mg/ml acyclovir (see ROUTE OF ADMINISTRATION).<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Kotra Pharma (M) Sdn Bhd
No. 1, 2 & 3, Jalan TTC 12,
Cheng Industrial Estate,
75250 Melaka, Malaysia
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                15 May 2023

            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>